Target intelligence / Profile preview

Gastric mucus and gastroduodenal mucosal surface

Molecular classification
Mucin, Glycoprotein, Biological barrier
01

Overview

The gastric mucus and gastroduodenal mucosal surface constitute a vital physiological defense system that shields the gastrointestinal epithelium from the caustic effects of gastric acid and the proteolytic enzyme pepsin (StatPearls: Physiology, Gastric Barrier [https://www.ncbi.nlm.nih.gov/books/NBK554439/]). This barrier is primarily composed of a hydrated gel layer of mucin glycoproteins, specifically MUC5AC and MUC6, which work in tandem with secreted bicarbonate to maintain a neutral pH at the cell surface (PubMed: Gastric Mucus [https://pubmed.ncbi.nlm.nih.gov/11588903/]). In addition to chemical protection, the mucus layer provides physical lubrication and acts as a sieve against pathogens like Helicobacter pylori. When this barrier is compromised by factors such as NSAIDs, alcohol, or infection, the resulting mucosal exposure leads to inflammation, erosions, and peptic ulcers. Therapeutic strategies targeting this surface include cytoprotective agents like sucralfate, which forms a protective paste over damaged tissue, and bismuth salts, which reinforce the barrier and provide antimicrobial activity (PubChem: Sucralfate [https://pubchem.ncbi.nlm.nih.gov/compound/Sucralfate]). These interventions are essential for restoring mucosal integrity and managing acid-related gastrointestinal disorders.

Other names
Gastric mucosal barrierGastroduodenal mucosal barrierGastric mucus layerGastric surface epithelium
02

Mechanism of action

Formation of a protective physical barrier; Stimulation of endogenous prostaglandin synthesis; Enhancement of mucus and bicarbonate secretion; Adsorption of pepsin and bile acids.

03

Biological functions

CytoprotectionAcid neutralizationLubricationPhysical barrier
04

Disease associations

Peptic ulcer diseaseGastritisGastroesophageal reflux disease (GERD)NSAID-induced gastropathyHelicobacter pylori infection
05

Safety considerations

ConstipationBlackening of stools and tongue (bismuth)Aluminum toxicity in renal impairment (sucralfate)Reduced absorption of other medications
06

Interacting drugs

Sucralfate

5 more in the full profile.

07

Biomarkers

Mucus layer thicknessMUC5AC expressionMUC6 expressionGastric bicarbonate secretion rate

Beyond the preview

Go deeper on Gastric mucus and gastroduodenal mucosal surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric mucus and gastroduodenal mucosal surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call